← FDA Drug Approvals (Drugs@FDA)

EVOCLIN

NDA · New Drug Application · Sponsor: NORVIUM BIOSCIENCE · Approved 2004-10-22

Drug application

FDA Application #

NDA050801

Application type

New Drug Application

Brand name

EVOCLIN

Generic name

Clindamycin Phosphate

Active ingredients

CLINDAMYCIN PHOSPHATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

NORVIUM BIOSCIENCE

First approval

2004-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown